Hypersensitive response elicitor-derived peptides and use thereof
Disclosed are hypersensitive-response eliciting peptides and non-hypersensitive response eliciting peptides that induce active plant responses, and that exhibit improved solubility, stability, resistance to chemical degradation, or a combination of these properties. Use of these peptides or fusion polypeptides, or DNA constructs encoding the same, for modulating plant biochemical signaling, imparting disease resistance to plants, enhancing plant growth, imparting tolerance to biotic stress, imparting tolerance and resistance to abiotic stress, imparting desiccation resistance to cuttings removed from ornamental plants, imparting post-harvest disease or post-harvest desiccation resistance to a fruit or vegetable, or enhancing the longevity of fruit or vegetable ripeness are also disclosed.
1. An isolated peptide that is between 13 and 50 amino acids in length, the peptide comprising the amino acid sequence of:
(SEQ ID NO: 2)
L-X-X-L-L-L-X-(F/L)-(I/L)-X-X-X-L
wherein
X at position 3 is optional and, when present, is selected from Asp (D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G), and
each X at positions 2, 7, 10, 11, and 12 is independently selected from Met (M), Ala (A), Asp (D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G); or
(ii)
(SEQ ID NO: 3)
(Q/E)-(Q/E)-(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-
(L/I/V/F)-X-(L/I/V/F)-(L/I/V/F)-X-X-X-
(L/I/V/F)-(D/G/Q/E)-(D/G/Q/E),
wherein
X at position 5 is optional and, when present, is selected from Asp (D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G), and
each X at positions 4, 9, 12, 13, and 14 is independently selected from Met (M), Ala (A), Asp(D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G); or
(iii)
(SEQ ID NO: 4)
(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-(L/I/V/F)-X-
(L/I/V/F)-(L/I/V/F)-X-X-X-(L/I/V/F)-
(D/G/Q/E)-(D/G/Q/E),
wherein
X at position 3 is optional and, when present, is selected from Asp (D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G), and
each X at positions 2, 7, 10, 11, and 12 is independently selected from Met (M), Ala (A), Asp (D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G); or
(iv)
(SEQ ID NO: 5)
(Q/E)-(Q/E)-(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-
(L/I/V/F)-X-(L/I/V/F)-(L/I/V/F)-X-X-X-
(L/I/V/F),
wherein
X at position 5 is optional and, when present, is selected from Asp (D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G), and
each X at positions 4, 9, 12, 13, and 14 is independently selected from Met (M), Ala (A), Asp (D), isoD, Glu (E), y-glutamate, Gln (Q), Asn (N), Ser (S), and Gly (G), wherein the peptide induces an active plant response, but does not induce a hypersensitive response, when applied to plant tissue, or wherein the peptide induces a hypersensitive plant response when applied to plant tissue.
2. The isolated peptide according to claim 1 , wherein X at position 3 of SEQ ID NO: 2 or 4 is not present; or X at position 5 of SEQ ID NO: 3 or 5 is not present.
3. The isolated peptide according to claim 1 , wherein X at position 3 of SEQ ID NO: 2 or 4 is present, and selected from D, isoD, E, y-glutamate, and Q; or wherein X at position 5 of SEQ ID NO: 3 or 5 is present, and selected from D, isoD, E, y-glutamate, and Q.
4. The isolated peptide according to claim 1 , wherein X at position 2 of SEQ ID NO: 2 or 4 is selected from the group consisting of D, isoD, E, and y-glutamate; or X at position 4 of SEQ ID NO: 3 or 5 is selected from the group consisting of D, isoD, E, and y-glutamate.
5. The isolated peptide according to claim 1 , wherein the peptide is free of cysteine and methionine.
6. The isolated peptide according to claim 1 , wherein X at position 7 of SEQ ID NO: 2 or 4 is selected from the group consisting of A, M, G, S, or E; or X at position 9 of SEQ ID NO: 3 or 5 is selected from the group consisting of A, M, G, S, or E.
7. The isolated peptide according to claim 1 , wherein each X at positions 10, 11, and 12 of SEQ ID NO: 2 or 4 is selected independently from the group consisting of M, A, G, S, and E; or each X at positions 12, 13, and 14 of SEQ ID NO: 3 or 5 is selected independently from the group consisting of M, A, G, S, and E.
8. The isolated peptide according to claim 1 further comprising a hydrophilic amino acid sequence at either the N-terminal or C-terminal end of SEQ ID NO: 2, 3, 4, or 5.
9. The isolated peptide according to claim 8 , wherein the hydrophilic amino acid sequence comprises from two to ten hydrophilic amino acid residues.
10. The isolated peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of:
(i)
(SEQ ID NO: 3)
(Q/E)-(Q/E)-(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-
(L/I/V/F)-X-(L/I/V/F)-(L/I/V/F)-X-X-X-
(L/I/V/F)-(D/G/Q/E)-(D/G/Q/E),
wherein
X at position 5 is optional and, when present, is selected from D, isoD, E, y-glutamate, Q, N, S, and G, and
each X at positions 4, 9, 12, 13, and 14 is independently selected from M, A, D, isoD, E, y-glutamate, Q, N, S, and G; or
(ii)
(SEQ ID NO: 4)
(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-(L/I/V/F)-X-
(L/I/V/F)-(L/I/V/F)-X-X-X-(L/I/V/F)-(D/G/Q/E)-
(D/G/Q/E),
wherein
X at position 3 is optional and, when present, is selected from D, isoD, E, y-glutamate, Q, N, S, and G, and
each X at positions 2, 7, 10, 11, and 12 is independently selected from M, A, D, isoD, E, y-glutamate, Q, N, S, and G; or
(iii)
(SEQ ID NO: 5)
(Q/E)-(Q/E)-(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-
(L/I/V/F)-X-(L/I/V/F)-(L/I/V/F)-X-X-X-
(L/I/V/F),
wherein
X at position 5 is optional and, when present, is selected from D, isoD, E, y-glutamate, Q, N, S, and G, and
each X at positions 4, 9, 12, 13, and 14 is independently selected from M, A, D, isoD, E, y-glutamate, Q, N, S, and G.
11. The isolated peptide according to claim 10 , wherein the peptide comprises the amino acid sequence of:
(i)
(SEQ ID NO: 3)
(Q/E)-(Q/E)-(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-
(L/I/V/F)-X-(L/I/V/F)-(L/I/V/F)-X-X-X-(L/I/V/F)-
(D/G/Q/E)-(D/G/Q/E),
wherein
X at position 5 is optional and, when present, is selected from D, isoD, E, y-glutamate, Q, N, S, and G, and
each X at positions 4, 9, 12, 13, and 14 is independently selected from M, A, D, isoD, E, y-glutamate, Q, N, S, and G; or
(ii)
(SEQ ID NO: 5)
(Q/E)-(Q/E)-(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-
(L/I/V/F)-X-(L/I/V/F)-(L/I/V/F)-X-X-X-(L/I/V/F),
wherein
X at position 5 is optional and, when present, is selected from D, isoD, E, y-glutamate, Q, N, S, and G, and
each X at positions 4, 9, 12, 13, and 14 is independently selected from M, A, D, isoD, E, y-glutamate, Q, N, S, and G.
12. The isolated peptide according to claim 10 , wherein the peptide comprises the amino acid sequence of:
(SEQ ID NO: 4)
(L/I/V/F)-X-X-(L/I/V/F)-(L/I/V/F)-(L/I/V/F)-X-
(L/I/V/F)-(L/I/V/F)-X-X-X-(L/I/V/F)-(D/G/Q/E)-
(D/G/Q/E),
wherein
X at position 3 is optional and, when present, is selected from D, isoD, E, y-glutamate, Q, N, S, and G; and
each X at positions 2, 7, 10, 11, and 12 is independently selected from M, A, D, isoD, E, y-glutamate, Q, N, S, and G.
13. The isolated peptide according to claim 11 , wherein the peptide consists essentially of the amino acid sequence of SEQ ID NO: 3 or SEQ ID NO: 5.
14. The isolated peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of one of SEQ ID NOS: 8-26, 28, 29, 31-33, 35-38, 40, 41, 46-48, 52, 62, 139, 545, or 546.
15. The isolated peptide according to claim 1 , wherein the isolated peptide has an average Kyte-Doolittle hydropathy index of less than 0.7.
16. The isolated peptide according to claim 1 , wherein the peptide induces an active plant response, but does not induce a hypersensitive response, when applied to plant tissue.
17. The isolated peptide according to claim 16 , wherein the peptide comprises the amino acid sequence of one of SEQ ID NOS: 140, 13, 15-19, 25-28, 36, and 51-53.
18. The isolated peptide according to claim 1 , wherein the peptide induces a hypersensitive response when applied to plant tissue.
19. The isolated peptide according to claim 18 , wherein the peptide comprises the amino acid sequence of one of SEQ ID NOS: 8-12, 139, 14, 20, 29, 33, 30, 50, 34, 54, 42, 55, 43, 56, 44, and 57.
20. The isolated peptide according to claim 1 , wherein the peptide is at least 90% pure.
21. The isolated peptide according to claim 1 wherein the peptide is a fusion polypeptide comprising a second amino acid sequence coupled via peptide bond to the amino acid sequence.
22. The isolated peptide according to claim 21 , wherein the second amino acid sequence includes a purification tag.
23. The isolated peptide according to claim 22 , wherein the second amino acid sequence further includes a cleavable linker sequence between the purification tag and the amino acid sequence.
24. The isolated peptide according to claim 21 , wherein the peptide is a fusion polypeptide comprising a first amino acid sequence for said peptide linked to a second amino acid sequence for said peptide.
25. A fusion polypeptide comprising a plurality of amino acid sequences linked together in series, each of the plurality of amino acid sequences comprising the peptide according to claim 1 .
26. A composition comprising one or more peptides according to claim 1 , and a carrier.
27. The composition according to claim 26 , wherein the composition is a clarified cell extract.
28. The composition according to claim 26 further comprising an additive selected from the group consisting of fertilizer, herbicide, insecticide, fungicide, nematicide, a bactericidal agent, a biological inoculant, a plant regulator, and mixtures thereof.
29. The composition according to claim 28 , wherein the composition comprises:
one or more of peptides according to SEQ ID NOS: 8, 14, 33, 52, 53, 71, and 58; and either
(i) clothianidin, a combination of clothianidin and Bacillus firmus , imidicloprid, or a combination of imidicloprid and Bacillus firmus ; or
(ii) thiamethoxam; a combination of thiamethoxam, mefenoxam, and fludioxynil; a combination of thiamethoxam, mefenoxam, fludioxynil and azoxystrobin; a combination of thiamethoxam and abamectin; a combination of thiamethoxam, abamectin, and a Pasteuria nematicide; or a combination of thiamethoxam, mefenoxam, fludioxynil, azoxystrobin, thiabendazole, and abamectin; or
(iii) a biological inoculant comprising a Bradyrhizobium spp., a Bacillus spp., and a combination thereof.
30. The composition according to claim 26 , wherein the carrier is an aqueous carrier optionally further comprising one or more of a biocidal agent, a protease inhibitor, a non-ionic surfactant, or a combination thereof.
31. The composition according to claim 26 , wherein the carrier is a solid carrier in particulate form.
32. The isolated peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of SEQ ID NO: 2.
33. The isolated peptide according to claim 32 , wherein the amino acid at position 8 is F and the amino acid at position 9 is I.
34. The isolated peptide according to claim 32 , wherein the peptide further comprises (Q/E)-(Q/E) residues immediately preceding SEQ ID NO: 2, (D/G/Q/E)-(D/G/Q/E) residues immediately following SEQ ID NO: 2, or both.
35. The isolated peptide according to claim 34 , wherein the peptide contains up to 20 amino acids preceding SEQ ID NO: 2 and up to 5 amino acids following SEQ ID NO: 2.
36. The isolated peptide according to claim 32 , wherein any Lys or Arg residues are changed to Glu and an Arg residue is introduced at the C-terminal end of said peptide.
37. An isolated peptide that is between 13 and 50 amino acids in length, the peptide comprising the amino acid sequence of:
(i) one of SEQ ID NOS: 8-26, 28, 29, 31-33, 35-38, 40, 41, 46-48, 52, 62, 139, 545, or 546; or
(ii) one of SEQ ID NOS: 8-26, 28, 29, 31-33, 35-38, 40, 41, 46-48, 52, 62, 139, 545, or 546 except that an Arg residue is introduced at the C-terminal end of said peptide.
38. The isolated peptide according to claim 37 , wherein the peptide consists essentially of the amino acid sequence of:
(i) one of SEQ ID NOS: 8-26, 28, 29, 31-33, 35-38, 40, 41, 46-48, 52, 62, 139, 545, or 546; or
(ii) one of SEQ ID NOS: 8-26, 28, 29, 31-33, 35-38, 40, 41, 46-48, 52, 62, 139, 545, or 546 except that an Arg residue is introduced at the C-terminal end of said peptide.
39. The isolated peptide according to claim 38 , wherein the peptide consists essentially of the amino acid sequence of SEQ ID NO: 33 or SEQ ID NO: 518.
40. A method of imparting disease resistance to plants comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to impart disease resistance.
41. A method of enhancing plant growth comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to enhance plant growth.
42. A method of increasing a plant's tolerance to biotic stress comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to increase the plant's tolerance to biotic stress factors selected from the group consisting of insects, arachnids, nematodes, weeds, and combinations thereof.
43. A method of increasing a plant's tolerance to abiotic stress comprising:
applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to increase the plant's tolerance to abiotic stress factors selected from the group consisting of salt stress, water stress, ozone stress, heavy metal stress, cold stress, heat stress, nutritional stress, and combinations thereof.